Skip to Content

9 3 5287 (Ropinirole 4 mg)

Pill imprint 9 3 5287 has been identified as Ropinirole hydrochloride 4 mg.

Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 4 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Ropinirole hydrochloride 4 mg 9 3 5287
Ropinirole hydrochloride
9 3
4 mg
7.00 mm
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Teva Pharmaceuticals USA
National Drug Code (NDC):
Inactive Ingredients:
croscarmellose sodium
hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
magnesium silicate
titanium dioxide
ferric oxide yellow
ferric oxide red
ferrosoferric oxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5914 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.